Molecular Medicine


Trent Lastinger & Associates is passionate and committed to partnering with companies that are on a mission to save lives through Molecular Medicine through Genomic Analysis and Molecular Diagnostics.  Genomic Analysis and molecular diagnostics allow for a more accurate and appropriate therapeutic, to be specifically aligned to the individual to best treat against critical infectious disease.

Trent Lastinger is the President and driving force serving the field of Molecular Medicine through Genomic analysis and Molecular Diagnostics. His impeccable track record, with a focus approach on accountable results has led to a history of exceeding his clients’ expectations. His success was directly related to his outstanding ability to identify and retain top talent within these markets. As a result, his practice is one of the most recognized within Genomic Analysis and Molecular Diagnostics. “Extraordinary people deliver extraordinary results.”

Our firm’s clients are involved with sciences that allow researchers to predict the probability of a drug response based on a person’s genetic makeup called Pharmacogenomics. Our clients are specifically involved with Gene Expression, and DNA Sequencing. 

  • Genomics
  • Genotyping for Single Nucleotide Polymorphisms (SNPs)
  • Research Nucleic Acid Test Applications
  • Research Blood Testing and Infectious Diseases
  • Research Diagnostic Testing using DNA
  • Gene Sequencing
  • Research Developments in Biochips for Clinical Applications
  • Pharmacogenomics